Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals announced that on September 10, 2026, its Board's Compensation Committee granted inducement awards to 14 new employees: non-qualified stock options to purchase 28,512 shares and 37,375 restricted stock units, under the company's 2020 Inducement Plan per Nasdaq Listing Rule 5635(c)(4). The options carry an exercise price of $100.61 per share -- equal to Mirum's September 10 close -- and vest over four years with a 25% one-year cliff; the RSUs vest over three years at 33% per anniversary, both contingent on continued employment.
Key figures
- Grant date
- 2026-09-10
- Rsu shares
- 37375
- New employees
- 14
- Option shares
- 28512
- Exercise price per share
- $100.61
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.